IRIS
MARONGIU, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.377
AS - Asia 1.825
EU - Europa 1.187
SA - Sud America 1.017
Continente sconosciuto - Info sul continente non disponibili 105
AF - Africa 70
OC - Oceania 5
Totale 7.586
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.238
BR - Brasile 854
SG - Singapore 777
IT - Italia 610
CN - Cina 329
HK - Hong Kong 261
VN - Vietnam 187
DE - Germania 145
FR - Francia 95
GB - Regno Unito 61
AR - Argentina 59
FI - Finlandia 58
CA - Canada 54
IN - India 38
MX - Messico 35
TR - Turchia 34
BD - Bangladesh 32
UA - Ucraina 32
RU - Federazione Russa 31
NL - Olanda 30
IQ - Iraq 25
VE - Venezuela 25
CO - Colombia 20
SE - Svezia 20
ZA - Sudafrica 20
EC - Ecuador 19
KR - Corea 18
PL - Polonia 18
ES - Italia 15
LT - Lituania 15
JP - Giappone 13
PK - Pakistan 13
UZ - Uzbekistan 13
AT - Austria 12
CZ - Repubblica Ceca 11
JM - Giamaica 11
AZ - Azerbaigian 10
BE - Belgio 10
CL - Cile 10
ID - Indonesia 9
KE - Kenya 9
PY - Paraguay 8
CR - Costa Rica 7
IL - Israele 7
MY - Malesia 7
PE - Perù 7
UY - Uruguay 7
BO - Bolivia 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
AU - Australia 5
DZ - Algeria 5
KZ - Kazakistan 5
MA - Marocco 5
NP - Nepal 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
GT - Guatemala 4
KG - Kirghizistan 4
NI - Nicaragua 4
PH - Filippine 4
SN - Senegal 4
SV - El Salvador 4
TH - Thailandia 4
BB - Barbados 3
EG - Egitto 3
GE - Georgia 3
GH - Ghana 3
HN - Honduras 3
OM - Oman 3
RO - Romania 3
AL - Albania 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GP - Guadalupe 2
GY - Guiana 2
IR - Iran 2
JO - Giordania 2
KW - Kuwait 2
LB - Libano 2
NO - Norvegia 2
PR - Porto Rico 2
PT - Portogallo 2
QA - Qatar 2
SC - Seychelles 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CD - Congo 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GM - Gambi 1
Totale 7.469
Salva come PNG Salva come JPEG
Città #
Dallas 1.207
Singapore 418
San Jose 368
Ashburn 279
Hong Kong 257
Beijing 131
Santa Clara 125
Council Bluffs 115
Chandler 78
Columbus 75
Munich 71
Ho Chi Minh City 67
Lauterbourg 61
São Paulo 58
Milan 57
Los Angeles 56
Cagliari 51
New York 46
Hanoi 43
Rome 41
Shanghai 40
Belo Horizonte 33
Boardman 32
Rio de Janeiro 28
Turku 26
Helsinki 25
Florence 24
Orem 22
Sassari 20
Atlanta 19
Bologna 19
Brooklyn 18
Phoenix 18
West Jordan 18
Chicago 17
Seoul 17
Brasília 16
Buenos Aires 16
Denver 16
Frankfurt am Main 16
Montreal 16
The Villages 16
Warsaw 16
Princeton 14
Boston 13
Buffalo 13
Jacksonville 13
Johannesburg 13
Nuremberg 13
Recife 13
Stockholm 13
Tashkent 13
Alghero 12
London 12
Poplar 12
Ankara 11
Catania 11
Falkenstein 11
Manaus 11
Salvador 11
Tokyo 11
Baku 10
Campinas 10
Chennai 10
Düsseldorf 10
Guarulhos 10
Kingston 10
Manchester 10
Mexico City 10
Vilnius 10
Baghdad 9
Curitiba 9
Goiânia 9
Guayaquil 9
Seattle 9
Brussels 8
Dhaka 8
Miano 8
Nairobi 8
Nova Iguaçu 8
Ribeirão Preto 8
Romola 8
Santiago 8
Trento 8
Brno 7
Genoa 7
Houston 7
Istanbul 7
Lappeenranta 7
Montebello 7
Pelotas 7
Selargius 7
The Dalles 7
Toronto 7
Wilmington 7
Amsterdam 6
Ann Arbor 6
Anápolis 6
Dearborn 6
Fortaleza 6
Totale 4.626
Salva come PNG Salva come JPEG
Nome #
The role of 123I-MIBG cardiac scintigraphy in the patients with movement disorders (MD). 353
The impact of risk factors ascertained at the surgery of the primary tumor on metastasis appearance and outcome of patients with papillary thyroid microcarcinoma (PTMC). 341
Brain 18F-FDG PET/CT usefulness in primary progressive aphasia variant diagnosis and in their development into Alzheimer’s disease or fronto-temporal dementia 254
131I-SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinomas (DTC) in long-term follow-up 197
123I-Ioflupane brain SPECT (I-SPECT) and brain parenchyma sonography (BPS) combined use in movement disorder diagnosis 187
Cortical metabolic 18F-FDG PET assessment and striatal dopamine transporter SPECT imaging in suspected early neurodegenerative disorders with uncertain movement and cognitive symptoms 170
18F-FDG PET/CT in patients with autoimmune encephalitis in the early stage. 163
The diagnostic usefulness of131i-spect/ct at both radioiodine ablation and during long-term follow-up in patients thyroidectomized for differentiated thyroid carcinoma: Analysis of tissue risk factors ascertained at surgery and correlated with metastasis appearance 159
Qualitative (Q) and semiquantitative (SQ) brain 18FFDG PET analyses in primary progressive aphasia (PPA) variants 156
18F-FDG Brain PET/CT Metabolic Imaging in Patients with Suspected Autoimmune Encephalitis (AE) in the Early Stage: Can the Procedure Play a Complementary Diagnostic Role? 154
18F-FDG brain and whole body (WB) PET/CT in intracranial leptomeningeal carcinomatosis and in paraneoplastic neurologic syndromes 149
The prognostic role of baseline and post neoadjuvant chemotherapy [18F]FDG PET/CT in triple-negative breast cancer: preliminary results of TRINE-PET trial 148
Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a 131I-SPECT/CT study. 147
Neck lymph node metastases in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a diagnostic 131I-SPECT/CT study 146
131I-SPECT/CT usefulness in patients with Hashimoto’s thyroiditis (HT) coexistence with papillary thyroid carcinoma (PC) without risk factors at surgery followed in a long-term follow-up after thyroidectomy and radioiodine ablation 143
Breast-Specific Gamma Imaging: An Added Value in the Diagnosis of Breast Cancer, a Systematic Review 142
Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma: A Follow-Up Study in Patients with Absence of Aggressive Risk Factors at the Surgery of the Primary Tumor 142
Axillary lymph node hypermetabolism (ALNH) related to COVID-19 vaccination in cancer patients undergoing 18F-FDG PET/CT: a single centre study on 500 cases 140
A multicenter 18F-FDG-PET/CT study in solitary pulmonary nodule: Qualitative and Semiquantitative parameters to predict the risk of malignancy 139
Qualitative and semiquantitative parameters in solitary pulmonary nodule: a multicenter 18F-FDG-PET/CT study 139
A Comparative Follow-Up Study of Patients with Papillary Thyroid Carcinoma Associated or Not with Graves' Disease 128
Large Italian Multicenter Study on Prognostic Value of Baselines Variables in mCRPC Patients Treated with 223RaCl2: Ten Years of Clinical Experience 128
Brain 123I-ioflupane SPECT and 18F-FDG PET combined use in movement and cognitive associated diseases of recent appearance 125
Differential Diagnosis of Alzheimer Disease vs. Mild Cognitive Impairment Based on Left Temporal Lateral Lobe Hypomethabolism on 18F-FDG PET/CT and Automated Classifiers 123
The prognostic role of [18F]FDG PET/CT for suspected recurrence or monitoring systemic treatment in triplenegative breast cancer: preliminary results of the TRINE-PET trial. 123
Harmonization of multi-center data for preliminary investigation of cardiac MIBG scintigraphy in Parkinsonism (ITA-MIBG STUDY): a novel approach using phantom calibration with tube and bottle. 123
131I-SPECT/CT at the first radioiodine ablation and during follow-up in patients with differentiated thyroid carcinoma (DTC). 123
Performance Analysis of Six Semi-Automated Tumour Delineation Methods on [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in Patients with Head and Neck Cancer 121
Pet-radiomics in lymphoma and multiple myeloma: update of current literature 120
131I-SPECT/CT after radioiodine therapy in patients with differentiated thyroid carcinoma 119
Multi-centre data harmonisation applied to heart-to-mediastinum quantification in parkinsonism (ITA-MIBG): a cross-calibration phantom study with tube and bottle 118
Prostate-Specific Membrane Antigen Radioligand Therapy in Non-Prostate Cancers: Where Do We Stand? 113
The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study 113
Radiomics analysis on PET/CT scans to discriminate malignant (adenocarcinoma) and benign pulmonary nodules 112
A multicenter study for the analysis of early onset Parkinson’s disease population: the role of 123I-FP-CIT and 123I-MIBG 112
Brain SPECT DAT imaging and 18F-FDG PET/CT combined use in the early stage of movement and cognitive associated neurodegenerative disorders 110
123I-MIBG Cardiac Scintigraphy and Heart/Mediastinum Ratio in Neurodegenerative Disorders: Is Delayed Scan Really Necessary? 110
The Role of Risk Factors for the Progression of Patients with T1b-T2 Papillary Thyroid Carcinoma (PC) during Long-Term Follow-Up 109
Prognostic role of the risk factors in the follow-up of T1B-T2 papillary thyroid carcinoma (PC) 109
Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy 109
Radiomics Features from Positron Emission Tomography with [18F] Fluorodeoxyglucose Can Help Predict Cervical Nodal Status in Patients with Head and Neck Cancer 109
The role of routine 131I-SPECT/CT use in differentiated thyroid carcinoma (DTC) follow-up 105
18F-FDG PET/CT (PET) and serum neurodegenerative biomarkers (NB) in suspected cognitive disorders (CD): a preliminary study 103
First-, Second-, and Third-Generation Radiolabeled Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Positron Emission Tomography: State of the Art, a Systematic Review 102
Evaluation of Bone Scan Index as a Prognostic Tool in Breast Cancer Patients with Bone Metastasis 102
Utility of shape and texture features from [18F]-FDG PET to predict cervical nodal status in patients with head & neck cancer 101
Minimal Extrathyroid Extension (mETE) as the Only Risk Factor in Patients with Papillary Thyroid Carcinoma (PC): Its Clinical Impact on Recurrence and Outcome during Long-Term Follow-Up 101
The prognostic role of baseline and post neoadjuvant chemotherapy [18F]FDG PET/CT in triple-negative breast cancer: preliminary results of the TRINE-PET trial 92
Qualitative and Semiquantitative Parameters of 18F-FDG-PET/CT as Predictors of Malignancy in Patients with Solitary Pulmonary Nodule 91
Usefulness of PET/CT with 18F-FDG in Patients with Differentiated Thyroid Carcinoma after Radioiodine Therapy: An Italian Multicenter Study 91
Prognostic role of minimal extrathyroidal tumor extension (mETE) in the follow-up of patients with papillary carcinoma (PC) unaffected by other risk factors. 89
Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer 85
Role of Functional Neuroimaging with 123I-MIBG and 123I-FP-CIT in De Novo Parkinson's Disease: A Multicenter Study 78
Radionuclide-based nanotechnologies in brain tumors: an updated overview 73
Long-term follow-up of patients thyroidectomized for thyroid papillary carcinoma (PC) with associated Graves’s disease (GD): a 131I-SPECT/CT diagnostic study 69
Artificial Intelligence in PET Imaging for Alzheimer’s Disease: A Narrative Review 52
The impact of [18F]FDG PET/CT in guiding the change of management of triple-negative breast cancer patients: a sub-analysis of the TRINE-PET trial 46
SPECT-based radiomics in oncology: current evidence, technical challenges, and future directions 41
Exploring the impact of Cabotegravir‐Rilpivirine long‐acting on weight gain, body composition and quality of life in adults living with HIV 39
Diagnostic Accuracy of DaTQUANT® Versus BasGanV2™ for 123I-Ioflupane Brain SPECT: A Machine Learning-Based Differentiation of Parkinson’s Disease and Essential Tremor 35
Machine learning for automated differentiation of parkinson’s disease and its mimics using ¹²³I-mIBG scintigraphy: insights from a multicentre real-world cohort (ITA-mIBG study) 35
Prognostic relevance of [18F]FDG PET/CT in triple-negative breast cancer: Results from the triple negative (TRINE)-PET trial. 16
From quantification to classification: comparative analysis of two software applications for machine learning–based prediction of early Parkinson’s disease using 123I-Ioflupane metrics 14
Totale 7.586
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.440
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.440
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202228 0 0 0 0 0 2 0 3 2 2 2 17
2022/2023153 8 14 2 35 8 30 4 15 26 2 6 3
2023/2024370 42 28 9 33 94 41 0 6 1 20 26 70
2024/20252.126 44 48 121 96 79 100 106 321 664 313 124 110
2025/20263.824 179 832 610 480 393 192 517 112 147 215 103 44
2026/2027968 80 266 274 348 0 0 0 0 0 0 0 0
Totale 7.586